drugset / Trial / NCT03908008
Efficacy and Safety Study of MT10107 in the Treatment of Glabella Line
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study design is a parallel, active drug controlled, double blind, randomized, multi-centered, phase III clinical trial to compare the efficacy and safety of MT10107 versus BOTOX® in treatment of glabella line.
Timeline
- Start
- 2014-01
- Primary completion
- 2014-05
- Completion
- 2014-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 20 iu | Intramuscular |
| Subject | CORETOX® | Unknown | 20 iu | Intramuscular |
Indications
No indication recorded.